PriceTracker GLP-1
Loading the index…

Try

Find the cheapest for me
Loading the index…

Try

GLP-1 TV

Zepbound KwikPen Is Here — 4 Doses in One Pen for $299? What You Need to Know

5:12Feb 2026

Today’s cheapest Zepbound$348/mo at Lemonaid Health, medication and membership billed separately.Compare all Zepbound prices Price read 22 Nov 2026 from the seller’s own page, ranked by price alone. Not from the video’s creator.

Our summary

According to the video, Eli Lilly has launched the Zepbound QuickPen, a multi-dose, single patient use prefilled pen that holds four weekly doses of tirzepatide. The creator says it replaces the weekly auto-injector or the vial-and-syringe routine, so one pen covers a month. It is injected under the skin in the abdomen, thigh, or upper arm, contains four fixed doses, and must be discarded after the fourth, even if the needle is changed. The creator lists six strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg, each giving one injection a week. The video says the FDA approved the device on January 20, 2026, and that the label covers adults with obesity, overweight adults with at least one weight-related condition, and adults with obesity and moderate to severe obstructive sleep apnea.

Published by Beyond the Scale: My GLP-1 Journey on YouTube

As published by the channel. Not medical advice, and not an endorsement.

What else the video covers

On price and access, the creator says cash-paying patients start at $299 per month for the 2.5 mg dose through Lilly Direct. A doctor sends the prescription to Lilly Direct, and the person then picks a fulfillment partner: Prescriptive, Amazon Pharmacy, Fuse Health, or Gift Health. The creator says insurance availability and coverage depend on the plan. The creator suggests that going from four devices a month to one could mean less packaging waste, fewer pharmacy shipments, a simpler routine, and possibly better adherence. The video also cites $4.2 billion in US Zepbound revenue in the fourth quarter, up 122% year over year, and notes that the QuickPen format is already used for Mounjaro for type 2 diabetes.

The creator lists several cautions: the pen is not recommended for visually impaired patients, it must be thrown away after four doses, the strength should be checked before each injection, and it remains a prescription medication that needs doctor supervision. The creator says the medication itself is unchanged and only the delivery differs, and asks whether it will improve adherence and whether competitors will respond.

Our summary of what is said, in our words. Doses, results and prices are the speaker’s, not advice.

Takeaways

The main points, in the order they come up. Tap a time to play from there.

  1. 0:05 The creator says Lilly has launched the Zepbound QuickPen, with a month of doses in one pen and prices starting at $299 a month for the lowest dose.
  2. 0:36 The video explains that the pen holds four fixed weekly doses of tirzepatide, is for one patient only, and must be discarded after the fourth dose.
  3. 1:08 According to the creator, the QuickPen comes in six strengths from 2.5 mg to 15 mg, and the FDA approved the device on January 20, 2026.
  4. 2:12 The creator says cash-paying patients can get the 2.5 mg dose from $299 per month through Lilly Direct, with insurance coverage varying by plan.
  5. 2:45 The creator suggests that cutting four devices a month to one could reduce waste and shipments and possibly help adherence.
  6. 3:46 The video lists cautions: not recommended for visually impaired patients, discard after four doses, verify the strength, and use doctor supervision.

Key moments

Tap one to play from there.

  1. 0:00 Introduction and What is the Zepbound KwikPen?
  2. 1:18 Zepbound KwikPen available doses and who it's approved for
  3. 2:05 Zepbound KwikPen prices and how to get it
  4. 2:39 How is the Zepbound KwikPen different from current options?
  5. 3:12 Why this matters and what to keep in mind when considering t

What the video says

As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.

Medication
Zepbound

Questions this video answers

How much does the Zepbound QuickPen cost?

The creator says cash-paying patients pay from $299 per month for the 2.5 mg dose through Lilly Direct. The video does not give prices for the higher strengths. For people using insurance, the creator says availability and coverage vary by plan.

How many doses are in a Zepbound QuickPen?

According to the video, each pen holds four fixed weekly doses of tirzepatide, one injection per week. It must be discarded after the fourth dose, and the creator says it is for single patient use only, even if the needle is changed.

How do you get the Zepbound QuickPen through Lilly Direct?

The creator says to talk to your doctor, who sends the prescription to Lilly Direct. You then choose a pharmacy fulfillment partner. The creator names Prescriptive, Amazon Pharmacy, Fuse Health, and Gift Health as the partners.

What strengths does the Zepbound QuickPen come in?

The creator says there are six strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg. Each strength still delivers one weekly injection.

Videos on the same question

The closest videos in the library by what is said in them, not by title.

Read next

Our guides closest to what this video covers, with prices checked weekly.

  • Zepbound KwikPen: how the four-dose pen works, what it costs and why Medicare covers it

    The Zepbound KwikPen is one pen that holds a month of Zepbound: four fixed weekly doses of the same strength. You attach a new pen needle each week (needles are not in the box), prime it, then turn the dose knob all the way and inject. It is the only Zepbound the Medicare GLP-1 Bridge covers, at a $50 copay per month's supply. Paying cash, Lilly's self-pay prices by strength and today's board prices are below.

  • Zepbound without insurance: every dose priced, and what the vial changes

    Without insurance, Zepbound costs $299 a month at the 2.5 mg starting dose and $399 at 5 mg, bought direct from Lilly. From 7.5 mg up the vial and the KwikPen are both $449 a month as long as each refill arrives within 45 days of the last; miss that window and it is $499 at 7.5 mg and $699 from 10 mg. That replaces a list price Lilly itself puts at $499 to $1,086.37 per fill. A year of 13 four-week fills at the trial doses is about $5,800 on refills kept on time and $9,087 at the regular price. Compounded tirzepatide, which is not FDA-approved, starts at $69 a month on our board.

  • Zepbound dosage chart: every tirzepatide dose, the escalation rule, what each rung lost in the trial, and what it costs

    Zepbound has six doses, 2.5 to 15 mg, taken once a week. The label's rule is four weeks at 2.5 mg, then 2.5 mg steps with at least four weeks on each, to a maintenance dose of 5, 10 or 15 mg. In SURMOUNT-1 those three doses lost 15.0, 19.5 and 20.9 percent of body weight over 72 weeks. Direct from Lilly each rung has a price, $299 at 2.5 mg rising to $699 at 10 mg and above, so the chart below carries the dose, the rule, the trial result and the bill in one place, plus the vial and KwikPen concentrations for anyone measuring in units.

Next steps

Zepbound prices

Insurance

Find more like it

Dose changeInjection techniqueCost and insurance

Up next

More from this collection

Watched it? See what it costs.

Every GLP-1 program we track, ranked by what actually leaves your account.

Back to GLP-1 TV